Quanterix Corp (NASDAQ:QTRX) — Market Cap & Net Worth
Market Cap & Net Worth: Quanterix Corp (QTRX)
Quanterix Corp (NASDAQ:QTRX) has a market capitalization of $162.55 Million ($162.55 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #17267 globally and #4044 in its home market, demonstrating a -11.22% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Quanterix Corp's stock price $3.48 by its total outstanding shares 46710797 (46.71 Million). See QTRX capex to operating cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Quanterix Corp Market Cap History: 2017 to 2026
Quanterix Corp's market capitalization history from 2017 to 2026. Data shows change from $1.00 Billion to $162.55 Million (-17.01% CAGR).
Index Memberships
Quanterix Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.01% | #477 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #1698 of 3165 |
Weight: Quanterix Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Quanterix Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Quanterix Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.67x
Quanterix Corp's market cap is 3.67 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $1.00 Billion | $22.87 Million | -$27.02 Million | 43.84x | N/A |
| 2018 | $855.27 Million | $37.63 Million | -$31.05 Million | 22.73x | N/A |
| 2019 | $1.10 Billion | $56.73 Million | -$40.80 Million | 19.46x | N/A |
| 2020 | $2.17 Billion | $86.38 Million | -$31.53 Million | 25.15x | N/A |
| 2021 | $1.98 Billion | $110.56 Million | -$57.69 Million | 17.91x | N/A |
| 2022 | $646.94 Million | $105.52 Million | -$99.57 Million | 6.13x | N/A |
| 2023 | $1.28 Billion | $121.14 Million | -$28.35 Million | 10.54x | N/A |
| 2024 | $496.54 Million | $135.44 Million | -$38.53 Million | 3.67x | N/A |
Competitor Companies of QTRX by Market Capitalization
Companies near Quanterix Corp in the global market cap rankings as of August 3, 2026.
Key companies related to Quanterix Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
Quanterix Corp Historical Marketcap From 2017 to 2026
Between 2017 and today, Quanterix Corp's market cap moved from $1.00 Billion to $ 162.55 Million, with a yearly change of -17.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $162.55 Million | -45.28% |
| 2025 | $297.08 Million | -40.17% |
| 2024 | $496.54 Million | -61.12% |
| 2023 | $1.28 Billion | +97.40% |
| 2022 | $646.94 Million | -67.33% |
| 2021 | $1.98 Billion | -8.82% |
| 2020 | $2.17 Billion | +96.78% |
| 2019 | $1.10 Billion | +29.06% |
| 2018 | $855.27 Million | -14.72% |
| 2017 | $1.00 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Quanterix Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $162.55 Million USD |
| MoneyControl | $162.55 Million USD |
| MarketWatch | $162.55 Million USD |
| marketcap.company | $162.55 Million USD |
| Reuters | $162.55 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Quanterix Corp
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa … Read more